BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11068141)

  • 21. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease.
    Behan DP; Heinrichs SC; Troncoso JC; Liu XJ; Kawas CH; Ling N; De Souza EB
    Nature; 1995 Nov; 378(6554):284-7. PubMed ID: 7477348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of alpha1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus.
    Sands SA; Morilak DA
    Neuroscience; 1999; 91(2):639-49. PubMed ID: 10366021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts.
    Lee S; Barbanel G; Rivier C
    Brain Res; 1995 Dec; 705(1-2):136-48. PubMed ID: 8821744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.
    Sajdyk TJ; Gehlert DR
    Brain Res; 2000 Sep; 877(2):226-34. PubMed ID: 10986336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus.
    Staub DR; Spiga F; Lowry CA
    Brain Res; 2005 May; 1044(2):176-89. PubMed ID: 15885216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
    Mansi JA; Rivest S; Drolet G
    Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of c-fos in restricted areas of the basal forebrain and brainstem following single or combined intraventricular infusions of vasopressin and corticotropin-releasing factor.
    Andreae LC; Herbert J
    Neuroscience; 1993 Apr; 53(3):735-48. PubMed ID: 8487952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
    Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system.
    Justice NJ; Yuan ZF; Sawchenko PE; Vale W
    J Comp Neurol; 2008 Dec; 511(4):479-96. PubMed ID: 18853426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticotropin-releasing hormone heterogeneous nuclear RNA (hnRNA) and immunoreactivity are induced in extrahypothalamic brain sites by kainic-acid-induced seizures and are modulated by estrogen.
    Foradori CD; Lund TD; Nagahara AH; Koenig JI; Handa RJ
    Brain Res; 2007 Aug; 1164():44-54. PubMed ID: 17631870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain.
    Rotllant D; Nadal R; Armario A
    Dev Neurobiol; 2007 May; 67(6):702-14. PubMed ID: 17443818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine modulation of stress-related peptide neurons.
    Loughlin SE; Islas MI; Cheng MY; Lee AG; Villegier AS; Leslie FM
    J Comp Neurol; 2006 Aug; 497(4):575-88. PubMed ID: 16739166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala.
    Scholl JL; Vuong SM; Forster GL
    Eur J Pharmacol; 2010 Oct; 644(1-3):80-7. PubMed ID: 20655906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary-adrenocortical and sympathoadrenal activity during stress.
    Jezova D; Ochedalski T; Glickman M; Kiss A; Aguilera G
    Neuroscience; 1999; 94(3):797-802. PubMed ID: 10579570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of corticotropin-releasing factor (CRF) receptor binding in the mouse brain using a new, high-affinity radioligand, [
    Tan LA; Vaughan JM; Perrin MH; Rivier JE; Sawchenko PE
    J Comp Neurol; 2017 Dec; 525(18):3840-3864. PubMed ID: 28842924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
    Skórzewska A; Lehner M; Hamed A; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Płaźnik A
    Behav Brain Res; 2011 Aug; 221(1):155-65. PubMed ID: 21376756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.